Autolus Therapeutics plc Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Autolus Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • Autolus Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.02M, a 40.4% increase year-over-year.
  • Autolus Therapeutics plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $12.5M.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2023 was $11.3M, a 6.36% decline from 2022.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $12M, a 20.9% increase from 2021.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $9.94M, a 50.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.3M -$764K -6.36% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $12M +$2.08M +20.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $9.94M -$10.1M -50.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $20M -$10.4M -34.1% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 $30.4M +$23.6M +349% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
2018 $6.77M +$3.61M +115% Oct 1, 2017 Sep 30, 2018 20-F 2020-03-03
2017 $3.15M +$896K +39.7% Oct 1, 2016 Sep 30, 2017 20-F 2020-03-03
2016 $2.26M Oct 1, 2015 Sep 30, 2016 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.